Health Tidings Mergers & AcquisitionsSentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Sentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Read Post »
Mergers & AcquisitionsJazz Pharmaceuticals to Acquire Actio Biosciences to Expand Rare Epilepsy P... Jazz Pharmaceuticals to Acquire Actio Biosciences to Expand Rare Epilepsy P... Read Post »
Health Tidings Mergers & AcquisitionsSobi enters strategic partnership with Innate Pharma to license lacutamab i... Sobi enters strategic partnership with Innate Pharma to license lacutamab i... Read Post »
Health Tidings Mergers & AcquisitionsBeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia BeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia Read Post »
Health Tidings Mergers & AcquisitionsEvotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Evotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Read Post »
Health Tidings Mergers & AcquisitionsOno and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Ono and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Read Post »
Manufacturing Mergers & AcquisitionsFujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Fujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Read Post »
Health Tidings Mergers & AcquisitionsEvexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Evexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Read Post »
Clinical Trials Mergers & AcquisitionsAmplia and Lilly Partner to Advance Narmafotinib Plus Olomorasib for KRAS G... Amplia and Lilly Partner to Advance Narmafotinib Plus Olomorasib for KRAS G... Read Post »
Health Tidings Mergers & AcquisitionsAbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers AbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers Read Post »
Health Tidings Mergers & AcquisitionsRelation, GSK Partner in $110M AI Drug Discovery Collaboration Relation, GSK Partner in $110M AI Drug Discovery Collaboration Read Post »
Mergers & AcquisitionsJohnson & Johnson Partners with Sail Biomedicines for In Vivo CAR-T The... Johnson & Johnson Partners with Sail Biomedicines for In Vivo CAR-T The... Read Post »
Mergers & AcquisitionsCSL Reports Positive Phase 3b Results for ANDEMBRY in Children With HAE CSL Reports Positive Phase 3b Results for ANDEMBRY in Children With HAE Read Post »
Mergers & AcquisitionsEntera Bio Positions EB613 for Phase 3 Osteoporosis Studies Entera Bio Positions EB613 for Phase 3 Osteoporosis Studies Read Post »
Health Tidings Mergers & AcquisitionsBioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... BioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... Read Post »
Health Tidings Mergers & Acquisitionsargenx Adds First-in-Class FB102 Through $2.2B Forte Biosciences Acquisitio... argenx Adds First-in-Class FB102 Through $2.2B Forte Biosciences Acquisitio... Read Post »
Health Tidings Mergers & AcquisitionsYarrow Bioscience Initiates Phase 2 Trial of Anti-TSHR Antibody YB-101 for ... Yarrow Bioscience Initiates Phase 2 Trial of Anti-TSHR Antibody YB-101 for ... Read Post »
Mergers & AcquisitionsArcus and Summit Launch Casdatifan–Ivonescimab Trial in Metastatic Kidney... Arcus and Summit Launch Casdatifan–Ivonescimab Trial in Metastatic Kidney... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Halozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Read Post »
Clinical Trials Mergers & AcquisitionsBayer Partners with Henry Ford Health to Expand Clinical Trials Bayer Partners with Henry Ford Health to Expand Clinical Trials Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and argenx Partner to Accelerate AI-Driven De Novo Antibody ... Chai Discovery and argenx Partner to Accelerate AI-Driven De Novo Antibody ... Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires AtaiBeckley to Advance BPL-003 for Treatment-Resistant Depre... Lilly Acquires AtaiBeckley to Advance BPL-003 for Treatment-Resistant Depre... Read Post »
Health Tidings Mergers & AcquisitionsNovartis Partners With Chai Discovery to Advance AI Antibody Discovery Novartis Partners With Chai Discovery to Advance AI Antibody Discovery Read Post »
Health Tidings Mergers & AcquisitionsSpero Secures Global Rights to Innovent’s Anti-CD40L Antibody IBI355 in U... Spero Secures Global Rights to Innovent’s Anti-CD40L Antibody IBI355 in U... Read Post »
Health Tidings Mergers & AcquisitionsAstraZeneca Licenses Zegfrovy from Dizal in Up to $1.5 Billion Deal to Expa... AstraZeneca Licenses Zegfrovy from Dizal in Up to $1.5 Billion Deal to Expa... Read Post »
Health Tidings Mergers & AcquisitionsIndonesia Grants Takeda Plasma Fractionation License for PDMP Production Indonesia Grants Takeda Plasma Fractionation License for PDMP Production Read Post »
Health Tidings Mergers & AcquisitionsSino Biopharma Secures China Rights to GSK’s Trelegy and Anoro Sino Biopharma Secures China Rights to GSK’s Trelegy and Anoro Read Post »
Health Tidings Mergers & AcquisitionsSerum Institute, DNDi Advance VIS513 Into Global Phase III Dengue Trial Serum Institute, DNDi Advance VIS513 Into Global Phase III Dengue Trial Read Post »
Health Tidings Mergers & AcquisitionsTeva Secures Global Rights to Polpharma Biologics’ Proposed Biosimilar to... Teva Secures Global Rights to Polpharma Biologics’ Proposed Biosimilar to... Read Post »
Health Tidings Mergers & AcquisitionsBayer Launches Clinical Trials Alliance With CU Anschutz Bayer Launches Clinical Trials Alliance With CU Anschutz Read Post »
Health Tidings Mergers & AcquisitionsSino Biopharmaceutical Licenses COPD Candidate TQC3721 to AstraZeneca in Up... Sino Biopharmaceutical Licenses COPD Candidate TQC3721 to AstraZeneca in Up... Read Post »
Health Tidings Mergers & AcquisitionsChemomab, Scipher Merge to Advance Nebokitug in Rheumatoid Arthritis Chemomab, Scipher Merge to Advance Nebokitug in Rheumatoid Arthritis Read Post »
Health Tidings Mergers & AcquisitionsPraxis Partners with Remagine Labs to Develop Transdermal Patch for Ulixaca... Praxis Partners with Remagine Labs to Develop Transdermal Patch for Ulixaca... Read Post »
Health Tidings Mergers & AcquisitionsVertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Vertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Read Post »
Health Tidings Mergers & AcquisitionsAstex Signs Breast Cancer Drug Discovery Deal with Genentech Astex Signs Breast Cancer Drug Discovery Deal with Genentech Read Post »
Health Tidings Mergers & AcquisitionsNovartis Acquires Myricx Bio to Advance Novel ADC Payload Technology Novartis Acquires Myricx Bio to Advance Novel ADC Payload Technology Read Post »
Health Tidings Mergers & AcquisitionsArcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher ... Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher ... Read Post »
Health Tidings Mergers & AcquisitionsTakeda Partners With Insilico Medicine in AI Drug Discovery Deal Worth Up t... Takeda Partners With Insilico Medicine in AI Drug Discovery Deal Worth Up t... Read Post »
Health Tidings Mergers & AcquisitionsUnited Therapeutics Acquires Thymmune to Expand T-Cell Regeneration Researc... United Therapeutics Acquires Thymmune to Expand T-Cell Regeneration Researc... Read Post »
Health Tidings Mergers & AcquisitionsIpsen Acquires Memo Therapeutics, Adds Potravitug to Rare Disease Pipeline Ipsen Acquires Memo Therapeutics, Adds Potravitug to Rare Disease Pipeline Read Post »
Health Tidings Mergers & AcquisitionsInnovent Secures Exclusive China Rights to Lilly’s Verzenios Innovent Secures Exclusive China Rights to Lilly’s Verzenios Read Post »
Health Tidings Mergers & AcquisitionsIpsen to Acquire Kartos Therapeutics in Up to $1.75B Deal, Adds Myelofibros... Ipsen to Acquire Kartos Therapeutics in Up to $1.75B Deal, Adds Myelofibros... Read Post »
Health Tidings Mergers & AcquisitionsElixirgen and Nippon Shinyaku Partner to Advance Full-Length Dystrophin mRN... Elixirgen and Nippon Shinyaku Partner to Advance Full-Length Dystrophin mRN... Read Post »
Health Tidings Mergers & AcquisitionsMerck KGaA to Acquire Bio-Techne for $11.3 Billion to Expand Life Science P... Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Expand Life Science P... Read Post »
Health Tidings Mergers & AcquisitionsNovartis Partners With Antares in Up to $1.9 Billion Oncology Drug Deal Novartis Partners With Antares in Up to $1.9 Billion Oncology Drug Deal Read Post »
Health Tidings Mergers & AcquisitionsIonis Partners with Recordati to Commercialize Zilganersen for Alexander Di... Ionis Partners with Recordati to Commercialize Zilganersen for Alexander Di... Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly Expands Abbisko Alliance in Up to $1.9 Billion Multi-Target Drug ... Eli Lilly Expands Abbisko Alliance in Up to $1.9 Billion Multi-Target Drug ... Read Post »
Health Tidings Mergers & AcquisitionsNuvectis Adds Late-Stage NXP100 and NXP200 in Haisco Licensing Deal Nuvectis Adds Late-Stage NXP100 and NXP200 in Haisco Licensing Deal Read Post »
Health Tidings Mergers & AcquisitionsInsilico and SK Biopharmaceuticals Pursue New Neuroimmune Treatments Using ... Insilico and SK Biopharmaceuticals Pursue New Neuroimmune Treatments Using ... Read Post »
Health Tidings Mergers & AcquisitionsAbbVie to Acquire Apogee Therapeutics for $10.9B, Expanding Immunology and ... AbbVie to Acquire Apogee Therapeutics for $10.9B, Expanding Immunology and ... Read Post »
